Page last updated: 2024-10-28

hydralazine and Nephrocalcinosis

hydralazine has been researched along with Nephrocalcinosis in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Nephrocalcinosis: A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wight, JP1
Bassett, AH1
Hutchesson, A1
Thurrell, W1
el Nahas, AM1

Other Studies

1 other study available for hydralazine and Nephrocalcinosis

ArticleYear
Effect of antihypertensive therapy in experimental chronic renal failure.
    Mineral and electrolyte metabolism, 1991, Volume: 17, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Dietary Proteins; Heart; Hydralazine; Kidney Failu

1991